ArticleRadiation oncology (London, England)2021

Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients.

Michela Buglione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.